Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Adele Fielding"'
Autor:
David I Marks, Matthew Beasley, Ronjon Chakraverty, Anna Castleton, Eduardo Olavarria, Maria Gilleece, Adele Fielding, George Mikhaeel, Patricia Diez, Aimee Jackson, Andrea Hodgkinson, Mohamed Elhanied
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Introduction The usage of a T-cell depleted, reduced intensity conditioning (RIC) approach to haematopoietic cell transplantation (HCT) in adult patients with acute lymphoblastic leukaemia (ALL) over 40 years of age and in first complete remission (C
Externí odkaz:
https://doaj.org/article/4f400c2c6f304009ab5e1c17162fd1b6
Publikováno v:
Viruses, Vol 8, Iss 10, p 294 (2016)
Oncolytic virotherapeutic agents are likely to become serious contenders in cancer treatment. The vaccine strain of measles virus is an agent with an impressive range of oncolytic activity in pre-clinical trials with increasing evidence of safety and
Externí odkaz:
https://doaj.org/article/2dcf312c22cb4e7988dd65da7e8fd377
Autor:
Adele Fielding
Publikováno v:
Blood. 139:645-646
Autor:
Adele K, Fielding, Adele, Fielding
Publikováno v:
Hematology. 2008:381-389
Despite the relatively low incidence of acute lymphoblastic leukemia (ALL) in adults, large national and international collaborations have recently improved our understanding of how to treat ALL in adults. This article documents and examines the curr
Autor:
Jacob M. Rowe, Georgina Buck, Adele Fielding, Martin S. Tallman, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Susan M. Richards, Hillard M. Lazarus, Letizia Foroni, Elisabeth Paietta, Mark R. Litzow, David Marks, Jill Durrant, Anthony H. Goldstone
Publikováno v:
Blood. 108:2-2
MRC UKALL XII / ECOG E2993 was initiated in 1993, to prospectively define the role of allogeneic transplant (allo), autologous transplant (auto) or chemotherapy in adult ALL in first CR up to age 60 (65 since 2004). All patients received two phases o
Autor:
Gordon W. Dewald, Anthony H. Goldstone, Jacob M. Rowe, Mark R. Litzow, Martin S. Tallman, Adele Fielding, Sue M. Richards, Christine J. Harrison, Anthony V. Moorman
Publikováno v:
Blood. 106:331-331
Background: Pre-treatment cytogenetics is a known predictor of outcome in haematological malignancies. However, its value in adult ALL is generally limited to the presence of the Philadelphia (Ph) translocation; mostly due to the low incidence of oth